LifeStance Health Group, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDLifeStance Health Group, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 88), indicating clear outperformance against the broad market. Earnings growth of 158% provides fundamental context to the price action. However, price is extended 21% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $8.02 | +14.84% | ABOVE |
| 50 SMA | $7.61 | +21.00% | ABOVE |
| 100 SMA | $7.20 | +27.88% | ABOVE |
| 150 SMA | $7.09 | +29.87% | ABOVE |
| 200 SMA | $6.66 | +38.30% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LFST in an uptrend right now?
LFST has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, LFST is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is LFST overbought or oversold?
LFST's RSI (14) is 69. The stock is in neutral territory, neither overbought nor oversold.
Is LFST outperforming the market?
LFST has a Relative Strength (RS) Rating of 88 out of 99. Yes, LFST is a market leader, outperforming 88% of all stocks over the past 12 months.
Where is LFST in its 52-week range?
LFST is trading at $9.21, which is 99% of its 52-week high ($9.29) and 98% above its 52-week low ($3.74).
How volatile is LFST?
LFST has a Beta of 1.01 and 52-week volatility of 56%. It's more volatile than the S&P 500 - expect bigger swings.